Spruce Biosciences, Inc.
SPRB
$60.95
$0.891.48%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 26.53% | -21.44% | -12.13% | -18.61% | -10.68% |
| Total Depreciation and Amortization | -54.35% | -52.83% | -46.67% | -43.94% | -34.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.31% | -72.54% | -60.78% | -9.73% | 32.69% |
| Change in Net Operating Assets | 91.55% | 90.06% | 55.81% | -151.38% | -182.76% |
| Cash from Operations | 40.45% | -2.26% | -3.86% | -47.44% | -68.19% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -26.82% | 0.00% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | 20,253.66% | -94.39% | -95.38% | -81.56% | -99.54% |
| Repurchase of Common Stock | -237.80% | -1.30% | -1.30% | 15.86% | 20.90% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 90.32% | -- |
| Cash from Financing | 2,780.70% | -18.66% | -18.85% | -11.76% | -103.30% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 117.63% | -27.46% | -91.73% | -867.75% | -180.38% |